PopoviciuMSPăduraruLYahyaGMetwallyKCavaluS. Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials. Int J Mol Sci. 2023; 24(13):10449.
2.
Elmaleh-SachsASchwartzJLBramanteCTNicklasJMGudzuneKAJayM. Obesity management in adults: a review. JAMA. 2023;330(20):2000-2015.
3.
Amat-SamaranchVAgut-BusquetEVilarrasaEPuigL. New perspectives on the treatment of hidradenitis suppurativa. Ther Adv Chronic Dis. 2021;12:20406223211055920. doi:10.1177/20406223211055920
4.
EmtestamLSartoriusK. Glucagon-like peptide-1 agonists for treatment of hidradenitis suppurativa. Br J Dermatol. 2017; 177:625-627.
5.
HenryTCahnBHaberR, et al. Therapeutic potential of GLP-1 agonists for hidradenitis suppurativa. Int J Dermatol. 2023; 62(12):1543-1544.